Medications that lower cortisol work through three main strategies: blocking the enzymes that produce cortisol, blocking cortisol from activating its receptors, or reducing the brain signals that tell the adrenal glands to make cortisol in the first place. These drugs are primarily prescribed for Cushing’s syndrome and related conditions where the body produces dangerously high levels of cortisol. They are not typically used for everyday stress, though some psychiatric medications can influence cortisol patterns indirectly.
Why Cortisol-Lowering Medication Exists
Your body produces cortisol through a chain of chemical reactions in the adrenal glands, which sit on top of your kidneys. Normally, the brain’s pituitary gland sends a hormone called ACTH to signal cortisol production, and cortisol in turn tells the brain to ease off. This feedback loop keeps levels in check. In Cushing’s syndrome, something breaks that loop, often a small pituitary tumor that keeps pumping out ACTH regardless of how much cortisol is already circulating.
Diagnosis typically involves collecting urine over 24 hours (two or three times, since results can vary by as much as 50% between samples) or measuring saliva cortisol late at night on consecutive days. A suppression test, where you take a small dose of a synthetic steroid at bedtime and have blood drawn the next morning, can also reveal whether the feedback loop is functioning. Once excess cortisol is confirmed, surgery to remove a tumor is usually the first option. Medication enters the picture when surgery fails, isn’t possible, or when cortisol needs to be controlled quickly while waiting for other treatments to take effect.
Drugs That Block Cortisol Production
The most commonly used cortisol-lowering medications are steroidogenesis inhibitors. These drugs interfere with the enzymes your adrenal glands need to convert cholesterol into cortisol. Three are widely used, each with a slightly different profile.
Ketoconazole
Originally developed as an antifungal, ketoconazole blocks multiple steps in the cortisol production chain. It hits a broader set of enzymes than other options, which makes it effective but also means it can reduce testosterone levels. That side effect makes long-term use less ideal for men. Ketoconazole is approved for cortisol lowering in Europe but used off-label in the United States. A newer, refined version called levoketoconazole received FDA approval specifically for Cushing’s syndrome.
Liver stress is the primary safety concern. The FDA prescribing information for levoketoconazole calls for weekly liver enzyme monitoring for at least the first six weeks, then every two weeks for another six weeks, then monthly for three more months. After any dose change or interruption, weekly monitoring restarts until levels stabilize. This is not a medication you take without close medical oversight.
Metyrapone
Metyrapone targets a narrower set of enzymes, specifically the final step where cortisol is assembled. It also reduces aldosterone, a hormone that regulates salt and water balance, which means some people experience fluid retention or changes in blood pressure. Metyrapone is approved in Europe and used off-label in the United States. It tends to work quickly, making it useful when cortisol needs to come down fast.
Osilodrostat
Osilodrostat blocks the same final enzymatic step as metyrapone and is the newest of the three, with approval from both the FDA and the European Medicines Agency. In the LINC 4 clinical trial extension, 72.4% of patients with Cushing’s disease achieved normal urinary cortisol levels by the end of the study. That’s a strong response rate for a condition that can be difficult to control.
Because both metyrapone and osilodrostat block the same enzyme, they can cause the body to reroute its hormone-making pathways, sometimes leading to an increase in male-type hormones. This can cause acne or excess hair growth, particularly in women. Doctors monitor for these shifts and adjust doses accordingly.
Drugs That Block Cortisol’s Effects
Rather than reducing how much cortisol your body makes, mifepristone prevents cortisol from doing its job. It works as a competitive blocker at the glucocorticoid receptor, essentially sitting in the receptor’s binding site so cortisol can’t activate it. The FDA approved mifepristone in 2012 specifically for controlling high blood sugar caused by excess cortisol in patients with Cushing’s syndrome who have type 2 diabetes or glucose intolerance and who either failed surgery or aren’t surgical candidates.
There’s an important catch with mifepristone: because it blocks the receptor rather than reducing cortisol production, your measured cortisol levels will actually rise. The brain senses that cortisol isn’t getting through and responds by telling the adrenals to make even more. This means doctors can’t use standard cortisol blood tests to gauge whether the drug is working. Instead, they track clinical improvements like blood sugar control, weight changes, and blood pressure. Mifepristone also blocks progesterone receptors, which means it’s not appropriate during pregnancy and can cause menstrual irregularities.
Drugs That Reduce the Brain’s Cortisol Signal
When Cushing’s disease is caused by a pituitary tumor, medications can target the tumor directly to reduce the amount of ACTH it releases. Less ACTH means less stimulation of the adrenal glands, and therefore less cortisol.
Pasireotide is a lab-made version of somatostatin, a natural hormone that puts the brakes on various hormone-secreting cells. It binds to receptors on the pituitary tumor cells and dials down ACTH secretion. It’s approved for Cushing’s disease when surgery has failed or isn’t an option. The main drawback is that it frequently raises blood sugar, sometimes enough to require diabetes medication.
Cabergoline, a dopamine-activating drug commonly used for other pituitary conditions, is used off-label for Cushing’s disease. Most ACTH-producing pituitary tumors have dopamine receptors, and stimulating those receptors can suppress ACTH release. Because both pasireotide and cabergoline work through different receptor types on the same tumor cells, doctors sometimes combine them in a stepwise approach to achieve faster or more complete cortisol control than either drug alone.
Mitotane for Severe or Refractory Cases
Mitotane stands apart from every other medication on this list. Rather than temporarily blocking enzymes or receptors, it physically destroys adrenal tissue. Derived from DDT (the insecticide), mitotane accumulates preferentially in the cortisol-producing zones of the adrenal glands, where its reactive byproducts bind irreversibly to the enzymes inside cells and cause cell death. This makes it extremely effective but essentially trades one problem for another: patients on long-term mitotane often develop adrenal insufficiency and need lifelong cortisol replacement at normal physiological doses.
Mitotane is reserved for adrenal cancer or severe Cushing’s syndrome that hasn’t responded to other treatments. It works slowly, sometimes taking weeks to months to reach therapeutic levels, and its side effects (nausea, fatigue, neurological symptoms) can be significant. Blood levels need regular monitoring to stay in the therapeutic window.
What About Medications for Stress-Related Cortisol?
If you searched this topic because you’re dealing with chronic stress rather than a diagnosed cortisol disorder, the medications above are not what you’re looking for. They carry serious side effects and are designed for pathologically elevated cortisol, not the moderately elevated levels associated with stress, poor sleep, or anxiety.
Some psychiatric medications do influence cortisol patterns, though that’s not their primary purpose. In a study of healthy volunteers, women taking the SSRI escitalopram for six days showed steeper cortisol curves across the day compared to placebo, with higher waking cortisol and a sharper decline by evening. This pattern, a strong morning peak followed by a clear drop, is actually the healthy ideal. Flattened cortisol rhythms (where levels stay moderately elevated all day without much variation) are associated with chronic stress and depression. The same effect was not seen in men in that study, and the drug did not change total daily cortisol output. So while SSRIs may help normalize cortisol timing in some people, they don’t simply lower cortisol across the board.
For stress-related cortisol elevation, the evidence more consistently supports behavioral approaches: regular physical activity, consistent sleep schedules, and stress reduction techniques. These aren’t as immediately satisfying as a pill, but they target the root cause rather than overriding a system that’s functioning as designed.